Pfizer's top products
Pfizer is a pharmaceutical corporation headquartered in New York City, United States. It was founded in 1849 by Charles Pfizer and Charles Erhart in Brooklyn, New York, where they produced an antiparasitic called santonin. Today, Pfizer produces pharmaceutical products for a wide range of medical sectors that include but are not limited to immunology, cardiology, and neurology. In 2015, Pfizer generated total revenue of 48.9 billion U.S. dollars worldwide with oncology products accumulating some three billion U.S. dollars. In the same year, Pfizer made about 44 percent of its revenues in the United States and eight percent in Japan.
Some of Pfizer’s top products include Lyrica and Celebrex, which generated 4.8 billion U.S. dollars and 0.83 billion U.S. dollars in revenue, respectively, in 2015. Pregabalin, marketed as Lyrica, is an anticonvulsant drug used to treat disorders such as epilepsy, diabetic peripheral neuropathy, and fibromyalgia. Lipitor, one of Pfizer’s more well-known products, generated revenue of 12.9 billion U.S. dollars in 2006, however, after Pfizer’s patent on Lipitor expired in 2011, revenue has fallen to under two billion U.S. dollars. Currently, generic forms of atorvastatin (Lipitor) are available. Lipitor is a statin that is used to lower blood cholesterol and to prevent cardiovascular diseases.